Literature DB >> 12050602

Minor segmental dyssynergy reflects extensive myocardial damage and global left ventricle dysfunction in chronic Chagas disease.

Oswaldo César de Almeida-Filho1, Benedito Carlos Maciel, André Schmidt, Antonio Pazin-Filho, José Antonio Marin-Neto.   

Abstract

The majority of patients with Chagas disease (ChD) remain for 10 to 30 years or even for life in the indeterminate form (IF) of this disease. They have positive-specific serology tests for ChD, but no symptoms or physical signs, and normal findings for electrocardiograms (ECGs) and heart, esophagus, and colon radiographs. To investigate whether patients in this phase of disease have any impairment of left ventricular (LV) systolic performance, we assessed their contractility index by the slope of the LV end-systolic pressure-dimension (P(es)-D(es)) relation. We studied 35 patients with ChD (14 IF, 11 digestive form [DF], 10 cardiac form [CF]) and 13 healthy subjects. Patients with the CF had only minor cardiac involvement (bundle-branch block, normal LV ejection fraction). All patients had normal baseline global LV systolic function on 2-dimensional echocardiography, but minor segmental wall motion abnormalities were observed in 3 DF, 3 IF, and 2 CF patients. At rest and during intravenous phenylephrine infusion, we measured LV dimensions by echocardiography, and LV end-systolic pressure was estimated by a calibrated carotid pulse tracing. We also measured percent fractional shortening (%DeltaD) and the rate-corrected mean velocity of fiber shortening (Vcf(c)). Mean values (+/- SD) of %DeltaD and Vcf(c) were not significantly different from those exhibited by healthy control subjects in any of the ChD groups at rest (except for CF) or at peak stress using phenylephrine. The P(es)-D(es) slope was similarly and significantly reduced in all ChD patients (IF: 50.7 +/- 25; DF: 52.3 +/- 24; CF: 60.8 +/- 22 mm Hg/cm) compared with normal subjects (89 +/- 17 mm Hg/cm). The P(es)-D(es) slope was even more depressed (39.6 +/- 10 mm Hg/cm) in ChD patients who had minor segmental wall motion abnormalities (SWMAs) on the baseline 2-dimensional echocardiograph in comparison with the slightly reduced values found in patients with CF who had isolated conduction abnormalities on the ECG (71.8 +/- 10 mm Hg/cm). Although %DeltaD and Vcf(c), even at peak afterload, do not differentiate ChD patients from normal controls, the P(es)-D(es) slope is significantly impaired in IF, DF, and CF patients. The remarkably lower P(es)-D(es) slope value documented in ChD patients exhibiting only minor LVWMAs suggests a more extensive myocardial damage in this group of patients, indicating that they should be considered as exhibiting symptoms of the CF version of the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12050602     DOI: 10.1067/mje.2002.117845

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  3 in total

1.  Dyskinesis in Chagasic myocardium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice.

Authors:  Jorge L Durand; Baiyu Tang; David E Gutstein; Stefka Petkova; Mauro M Teixeira; Herbert B Tanowitz; Linda A Jelicks
Journal:  Magn Reson Imaging       Date:  2006-05-26       Impact factor: 2.546

2.  Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure.

Authors:  R J Viotti; C Vigliano; S Laucella; B Lococo; M Petti; G Bertocchi; B Ruiz Vera; H Armenti
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

3.  Histopathological Correlates of Global and Segmental Left Ventricular Systolic Dysfunction in Experimental Chronic Chagas Cardiomyopathy.

Authors:  Luciano Fonseca Lemos de Oliveira; Minna Moreira Dias Romano; Eduardo Elias Vieira de Carvalho; Jorge Mejia Cabeza; Hélio Cesar Salgado; Rubens Fazan Júnior; Renata Sesti Costa; João Santana da Silva; Maria de Lourdes Higuchi; Benedito Carlos Maciel; Edécio Cunha-Neto; José Antônio Marin-Neto; Marcus Vinícius Simões
Journal:  J Am Heart Assoc       Date:  2016-01-21       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.